Kaplan Steven A
Institute for Bladder and Prostate Health, Weill Cornell Medical College of Cornell University New York, NY.
Rev Urol. 2009 Fall;11(Suppl 1):S14-8.
There are currently 5 alpha-blockers that are approved by the US Food and Drug Administration to treat lower urinary tract symptoms (LUTS). The American Urological Association guidelines committee believes that all alpha-blockers are equally effective. However, alpha-blockers differ in their likelihood of causing abnormal ejaculation. This article discusses the effects on ejaculatory function, and specifically retrograde ejaculation, of the currently available alpha-blockers being used to treat men with LUTS due to benign prostatic hyperplasia.
目前有5种α受体阻滞剂已获美国食品药品监督管理局批准用于治疗下尿路症状(LUTS)。美国泌尿外科学会指南委员会认为,所有α受体阻滞剂的疗效相当。然而,不同α受体阻滞剂导致异常射精的可能性存在差异。本文探讨了目前用于治疗因良性前列腺增生导致下尿路症状的男性患者的α受体阻滞剂对射精功能的影响,特别是逆行射精的影响。